Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
28.58
-0.30 (-1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Simulations Plus Revenue
In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth. Simulations Plus had revenue of $18.66M in the quarter ending August 31, 2024, with 19.42% growth.
Revenue (ttm)
$70.01M
Revenue Growth
+17.52%
P/S Ratio
8.16
Revenue / Employee
$283,453
Employees
247
Market Cap
573.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 1.45B |
Varex Imaging | 811.00M |
InnovAge Holding | 786.51M |
Fulgent Genetics | 277.76M |
SI-BONE | 157.04M |
Surmodics | 126.08M |
Capricor Therapeutics | 23.23M |
Altimmune | 52.00K |
SLP News
- 4 days ago - Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date - Business Wire
- 4 weeks ago - Simulations Plus to Participate in the BTIG Digital Health Forum - Business Wire
- 5 weeks ago - Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables - Business Wire
- 6 weeks ago - Simulations Plus to Participate in the Stephens Annual Investment Conference - Business Wire
- 7 weeks ago - Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire
- 2 months ago - Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results - Business Wire
- 2 months ago - Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date - Business Wire